Benjamin Edwards Inc. Increases Position in Encompass Health Co. (NYSE:EHC)

Posted by on Jul 17th, 2023

Benjamin Edwards Inc. increased its holdings in shares of Encompass Health Co. (NYSE:EHC – Free Report) by 142.6% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 575 shares of the company’s stock after acquiring an additional 338 shares during the quarter. Benjamin Edwards Inc.’s holdings in Encompass Health were worth $31,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of EHC. Belpointe Asset Management LLC purchased a new position in shares of Encompass Health in the 4th quarter worth about $25,000. Quadrant Capital Group LLC increased its stake in shares of Encompass Health by 358.5% during the 4th quarter. Quadrant Capital Group LLC now owns 431 shares of the company’s stock worth $26,000 after purchasing an additional 337 shares during the last quarter. U.S. Capital Wealth Advisors LLC purchased a new stake in shares of Encompass Health during the 4th quarter worth approximately $30,000. Worth Asset Management LLC purchased a new position in Encompass Health in the first quarter valued at approximately $35,000. Finally, Lazard Asset Management LLC grew its holdings in Encompass Health by 14.3% during the fourth quarter. Lazard Asset Management LLC now owns 1,290 shares of the company’s stock valued at $77,000 after purchasing an additional 161 shares during the period. Institutional investors own 92.78% of the company’s stock.

Encompass Health Price Performance

Shares of Encompass Health stock opened at $67.26 on Monday. The stock has a market capitalization of $6.74 billion, a price-to-earnings ratio of 24.91, a price-to-earnings-growth ratio of 1.80 and a beta of 1.07. The company has a fifty day moving average of $63.77 and a 200-day moving average of $60.92. Encompass Health Co. has a 52-week low of $45.11 and a 52-week high of $67.90. The company has a debt-to-equity ratio of 1.41, a quick ratio of 1.29 and a current ratio of 1.29.

Encompass Health (NYSE:EHC – Get Free Report) last released its earnings results on Friday, April 28th. The company reported $0.88 earnings per share for the quarter, beating analysts’ consensus estimates of $0.70 by $0.18. Encompass Health had a return on equity of 16.80% and a net margin of 5.75%. The company had revenue of $1.16 billion during the quarter, compared to analyst estimates of $1.14 billion. During the same quarter in the previous year, the company posted $0.97 EPS. Encompass Health’s revenue for the quarter was down 13.0% on a year-over-year basis. Equities research analysts expect that Encompass Health Co. will post 3.19 EPS for the current year.

Encompass Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, July 17th. Stockholders of record on Monday, July 3rd will be paid a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.89%. The ex-dividend date of this dividend is Friday, June 30th. Encompass Health’s payout ratio is 22.22%.

Analyst Upgrades and Downgrades

EHC has been the topic of a number of recent research reports. Mizuho upped their price target on Encompass Health from $69.00 to $74.00 in a research report on Monday, May 1st. Bank of America boosted their target price on shares of Encompass Health from $69.00 to $74.00 in a report on Friday, April 28th. Royal Bank of Canada boosted their price objective on Encompass Health from $66.00 to $70.00 in a research note on Tuesday, May 2nd. Deutsche Bank Aktiengesellschaft raised their target price on Encompass Health from $70.00 to $73.00 in a research note on Monday, May 1st. Finally, Stephens raised their price objective on shares of Encompass Health from $74.00 to $78.00 in a research report on Thursday, June 29th. One research analyst has rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Buy” and an average target price of $71.64.

Encompass Health Profile

(Free Report)

Encompass Health Corporation provides post-acute healthcare services in the United States. It provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.

See Also

Institutional Ownership by Quarter for Encompass Health (NYSE:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.